A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
NCT00301483
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Wounds and Injuries
Interventions
DRUG:
Hemoglobin-based oxygen carrier-201 (HBOC 201)
OTHER:
Standard of Care
Sponsor
Biopure Corporation